nach oben

European Journal of Nutrition

Erschienen in:

01.03.2015 | Original Contribution

Autophagy inhibitor 3-methyladenine potentiates apoptosis induced by dietary tocotrienols in breast cancer cells

verfasst von: Anh Thu Tran, Malathi Ramalinga, Habib Kedir, Robert Clarke, Deepak Kumar

Erschienen in: European Journal of Nutrition | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Tocomin^® represents commercially available mixture of naturally occurring tocotrienols (T3s) and tocopherols extracted from palm oil/palm fruits that possess powerful antioxidant, anticancer, neuro/cardioprotective and cholesterol-lowering properties. Cellular autophagy represents a defense mechanism against oxidative stress and several anticancer compounds. Recently, we reported that T3s induce apoptosis and endoplasmic reticulum stress in breast cancer cells.

Methodology

We studied the effects of Tocomin^® on MCF-7 and MDA-MB 231 breast cancer cells and non-tumor MCF-10A cells.

Results

Tocomin^® inhibited cell proliferation and induced apoptosis in both MCF-7 and MDA-MB 231 breast cancer cell lines without affecting the viability of MCF-10A cells. We also showed that Tocomin^® negatively modulates phosphoinositide 3-kinase and mTOR pathways and induces cytoprotective autophagic response in triple negative MDA-MB 231 cells. Lastly, we demonstrate that autophagy inhibitor 3-methyladenine (3-MA) potentiated the apoptosis induced by Tocomin^® in MDA-MB 231 cells.

Conclusion

Together, our data indicate anticancer effects of Tocomin^® in breast cancer cells, which is potentiated by the autophagy inhibitor 3-MA.

Nesaretnam K, Ambra R, Selvaduray KR, Radhakrishnan A, Canali R, Virgili F (2004) Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells. Ann NY Acad Sci 1031:143–157CrossRef

Komiyama K, Iizuka K, Yamaoka M, Watanabe H, Tsuchiya N, Umezawa I (1989) Studies on the biological activity of tocotrienols. Chem Pharm Bull (Tokyo) 37(5):1369–1371CrossRef

Sen CK, Khanna S, Rink C, Roy S (2007) Tocotrienols: the emerging face of natural vitamin E. Vitam Horm 76:203–261CrossRef

Noguchi N, Hanyu R, Nonaka A, Okimoto Y, Kodama T (2003) Inhibition of THP-1 cell adhesion to endothelial cells by alpha-tocopherol and alpha-tocotrienol is dependent on intracellular concentration of the antioxidants. Free Radic Biol Med 34(12):1614–1620CrossRef

Srivastava JK, Gupta S (2006) Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem Biophys Res Commun 346(2):447–453CrossRef

Sakai M, Okabe M, Yamasaki M, Tachibana H, Yamada K (2004) Induction of apoptosis by tocotrienol in rat hepatoma dRLh-84 cells. Anticancer Res 24(3a):1683–1688

Ling MT, Luk SU, Al-Ejeh F, Khanna KK (2011) Tocotrienol as a potential anticancer agent. Carcinogenesis. doi:10.1093/carcin/bgr261

Nesaretnam K, Meganathan P, Veerasenan SD, Selvaduray KR (2012) Tocotrienols and breast cancer: the evidence to date. Genes Nutr 7(1):3–9. doi:10.1007/s12263-011-0224-z CrossRef

Sylvester PW, Wali VB, Bachawal SV, Shirode AB, Ayoub NM, Akl MR (2012) Tocotrienol combination therapy results in synergistic anticancer response. Front Biosci: J Virtual Libr 17:3183–3195

10.

Kannappan R, Gupta SC, Kim JH, Aggarwal BB (2012) Tocotrienols fight cancer by targeting multiple cell signaling pathways. Genes Nutr 7(1):43–52. doi:10.1007/s12263-011-0220-3 CrossRef

11.

de Mesquita ML, Araujo RM, Bezerra DP, Filho RB, de Paula JE, Silveira ER, Pessoa C, de Moraes MO, Costa Lotufo LV, Espindola LS (2011) Cytotoxicity of delta-tocotrienols from Kielmeyera coriacea against cancer cell lines. Bioorg Med Chem 19(1):623–630. doi:10.1016/j.bmc.2010.10.044 CrossRef

12.

Luk SU, Yap WN, Chiu YT, Lee DT, Ma S, Lee TK, Vasireddy RS, Wong YC, Ching YP, Nelson C, Yap YL, Ling MT (2011) Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. Int J Cancer 128(9):2182–2191. doi:10.1002/ijc.25546 CrossRef

13.

Taridi NM, Yahaya MF, Teoh SL, Latiff AA, Ngah WZ, Das S, Mazlan M (2011) Tocotrienol rich fraction (TRF) supplementation protects against oxidative DNA damage and improves cognitive functions in Wistar rats. La Clinica terapeutica 162(2):93–98

14.

Ren Z, Pae M, Dao MC, Smith D, Meydani SN, Wu D (2010) Dietary supplementation with tocotrienols enhances immune function in C57BL/6 mice. J Nutr 140(7):1335–1341. doi:10.3945/jn.110.121434 CrossRef

15.

Hafid SR, Radhakrishnan AK, Nesaretnam K (2010) Tocotrienols are good adjuvants for developing cancer vaccines. BMC Cancer 10:5. doi:10.1186/1471-2407-10-5 CrossRef

16.

Shah SJ, Sylvester PW (2005) Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity. Exp Biol Med (Maywood) 230(4):235–241

17.

Shah S, Sylvester PW (2004) Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells. Exp Biol Med (Maywood) 229(8):745–755

18.

Shin-Kang S, Ramsauer VP, Lightner J, Chakraborty K, Stone W, Campbell S, Reddy SA, Krishnan K (2011) Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway. Free Radic Biol Med 51(6):1164–1174. doi:10.1016/j.freeradbiomed.2011.06.008 CrossRef

19.

Katuru R, Fernandes NV, Elfakhani M, Dutta D, Mills N, Hynds DL, King C, Mo H (2011) Mevalonate depletion mediates the suppressive impact of geranylgeraniol on murine B16 melanoma cells. Exp Biol Med 236(5):604–613. doi:10.1258/ebm.2011.010379 CrossRef

20.

Elangovan S, Hsieh TC, Wu JM (2008) Growth inhibition of human MDA-mB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product. Anticancer Res 28(5A):2641–2647

21.

Loganathan R, Selvaduray KR, Nesaretnam K, Radhakrishnan AK (2013) Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP-ribose) polymerase cleavage and inhibiting nuclear factor kappa-B activity. Cell Prolif 46(2):203–213. doi:10.1111/cpr.12014 CrossRef

22.

Gopalan A, Yu W, Jiang Q, Jang Y, Sanders BG, Kline K (2012) Involvement of de novo ceramide synthesis in gamma-tocopherol and gamma-tocotrienol-induced apoptosis in human breast cancer cells. Mol Nutr Food Res 56(12):1803–1811. doi:10.1002/mnfr.201200350 CrossRef

23.

Liu HK, Wang Q, Li Y, Sun WG, Liu JR, Yang YM, Xu WL, Sun XR, Chen BQ (2010) Inhibitory effects of gamma-tocotrienol on invasion and metastasis of human gastric adenocarcinoma SGC-7901 cells. J Nutr Biochem 21(3):206–213. doi:10.1016/j.jnutbio.2008.11.004 CrossRef

24.

Xu YW, Wang B, Ding CH, Li T, Gu F, Zhou C (2011) Differentially expressed micoRNAs in human oocytes. J Assist Reprod Genet 28(6):559–566. doi:10.1007/s10815-011-9590-0 CrossRef

25.

Nesaretnam K, Ambra R, Selvaduray KR, Radhakrishnan A, Reimann K, Razak G, Virgili F (2004) Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice. Lipids 39(5):459–467CrossRef

26.

Takahashi K, Loo G (2004) Disruption of mitochondria during tocotrienol-induced apoptosis in MDA-MB-231 human breast cancer cells. Biochem Pharmacol 67(2):315–324CrossRef

27.

Constantinou C, Neophytou CM, Vraka P, Hyatt JA, Papas KA, Constantinou AI (2011) Induction of DNA damage and caspase-independent programmed cell death by Vitamin E. Nutr Cancer. doi:10.1080/01635581.2012.630167

28.

Agarwal MK, Agarwal ML, Athar M, Gupta S (2004) Tocotrienol-rich fraction of palm oil activates p53, modulates Bax/Bcl2 ratio and induces apoptosis independent of cell cycle association. Cell Cycle 3(2):205–211CrossRef

29.

Patacsil D, Tran AT, Cho YS, Suy S, Saenz F, Malyukova I, Ressom H, Collins SP, Clarke R, Kumar D (2012) Gamma-tocotrienol induced apoptosis is associated with unfolded protein response in human breast cancer cells. J Nutr Biochem 23(1):93–100. doi:10.1016/j.jnutbio.2010.11.012 CrossRef

30.

Kouroku Y, Fujita E, Tanida I, Ueno T, Isoai A, Kumagai H, Ogawa S, Kaufman RJ, Kominami E, Momoi T (2007) ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ 14(2):230–239. doi:10.1038/sj.cdd.4401984 CrossRef

31.

Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S, Murakami T, Taniguchi M, Tanii I, Yoshinaga K, Shiosaka S, Hammarback JA, Urano F, Imaizumi K (2006) Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 26(24):9220–9231. doi:10.1128/MCB.01453-06 CrossRef

32.

Rouschop KM, van den Beucken T, Dubois L, Niessen H, Bussink J, Savelkouls K, Keulers T, Mujcic H, Landuyt W, Voncken JW, Lambin P, van der Kogel AJ, Koritzinsky M, Wouters BG (2010) The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Investig 120(1):127–141. doi:10.1172/JCI40027 CrossRef

33.

Lee H, Noh JY, Oh Y, Kim Y, Chang JW, Chung CW, Lee ST, Kim M, Ryu H, Jung YK (2012) IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux. Hum Mol Genet 21(1):101–114. doi:10.1093/hmg/ddr445 CrossRef

34.

Shi YH, Ding ZB, Zhou J, Hui B, Shi GM, Ke AW, Wang XY, Dai Z, Peng YF, Gu CY, Qiu SJ, Fan J (2011) Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy 7(10):1159–1172. doi:10.4161/auto.7.10.16818 CrossRef

35.

Nishikawa T, Tsuno NH, Okaji Y, Shuno Y, Sasaki K, Hongo K, Sunami E, Kitayama J, Takahashi K, Nagawa H (2010) Inhibition of autophagy potentiates sulforaphane-induced apoptosis in human colon cancer cells. Ann Surg Oncol 17(2):592–602. doi:10.1245/s10434-009-0696-x CrossRef

36.

Carew JS, Medina EC, Esquivel JA 2nd, Mahalingam D, Swords R, Kelly K, Zhang H, Huang P, Mita AC, Mita MM, Giles FJ, Nawrocki ST (2010) Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation. J Cell Mol Med 14(10):2448–2459. doi:10.1111/j.1582-4934.2009.00832.x CrossRef

37.

Livesey KM, Tang D, Zeh HJ, Lotze MT (2009) Autophagy inhibition in combination cancer treatment. Curr Opin Investig Drugs 10(12):1269–1279

38.

Ren Y, Huang F, Liu Y, Yang Y, Jiang Q, Xu C (2009) Autophagy inhibition through PI3K/Akt increases apoptosis by sodium selenite in NB4 cells. BMB Rep 42(9):599–604CrossRef

39.

Hou YJ, Dong LW, Tan YX, Yang GZ, Pan YF, Li Z, Tang L, Wang M, Wang Q, Wang HY (2011) Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma. Lab Invest 91(8):1146–1157. doi:10.1038/labinvest.2011.97 CrossRef

40.

Xie BS, Zhao HC, Yao SK, Zhuo DX, Jin B, Lv DC, Wu CL, Ma DL, Gao C, Shu XM, Ai ZL (2011) Autophagy inhibition enhances etoposide-induced cell death in human hepatoma G2 cells. Int J Mol Med 27(4):599–606. doi:10.3892/ijmm.2011.607

41.

Chen LH, Loong CC, Su TL, Lee YJ, Chu PM, Tsai ML, Tsai PH, Tu PH, Chi CW, Lee HC, Chiou SH (2011) Autophagy inhibition enhances apoptosis triggered by BO-1051, an N-mustard derivative, and involves the ATM signaling pathway. Biochem Pharmacol 81(5):594–605. doi:10.1016/j.bcp.2010.12.011 CrossRef

42.

Shibata A, Nakagawa K, Shirakawa H, Kobayashi T, Kawakami Y, Takashima R, Ohashi A, Sato S, Ohsaki Y, Kimura F, Kimura T, Tsuduki T, Komai M, Miyazawa T (2012) Physiological effects and tissue distribution from large doses of tocotrienol in rats. Biosci Biotechnol Biochem 76(9):1805–1808CrossRef

43.

Nesaretnam K, Dorasamy S, Darbre PD (2000) Tocotrienols inhibit growth of ZR-75-1 breast cancer cells. Int J Food Sci Nutr 51(Suppl):S95–S103CrossRef

44.

Nesaretnam K, Stephen R, Dils R, Darbre P (1998) Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33(5):461–469CrossRef

45.

Miyoshi N, Wakao Y, Tomono S, Tatemichi M, Yano T, Ohshima H (2011) The enhancement of the oral bioavailability of gamma-tocotrienol in mice by gamma-cyclodextrin inclusion. J Nutr Biochem 22(12):1121–1126. doi:10.1016/j.jnutbio.2010.09.011 CrossRef

46.

Fu JY, Che HL, Tan DM, Teng KT (2014) Bioavailability of tocotrienols: evidence in human studies. Nutr Metab 11(1):5. doi:10.1186/1743-7075-11-5 CrossRef

47.

Yap SP, Yuen KH, Wong JW (2001) Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status. J Pharm Pharmacol 53(1):67–71CrossRef

Titel: Autophagy inhibitor 3-methyladenine potentiates apoptosis induced by dietary tocotrienols in breast cancer cells
verfasst von: Anh Thu Tran
Malathi Ramalinga
Habib Kedir
Robert Clarke
Deepak Kumar
Publikationsdatum: 01.03.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition / Ausgabe 2/2015
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-014-0707-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Autophagy inhibitor 3-methyladenine potentiates apoptosis induced by dietary tocotrienols in breast cancer cells

Abstract

Introduction

Methodology

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Introduction

Methodology

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2015

The effect of high-fat–high-fructose diet on skeletal muscle mitochondrial energetics in adult rats

Habitual consumption of coffee and green tea in relation to serum adipokines: a cross-sectional study

Can consumption of raw vegetables decrease the count of sister chromatid exchange? Results from a cross-sectional study in Krakow, Poland

Dose–response meta-analysis of poultry intake and colorectal cancer incidence and mortality

Protective effect of KI in mtDNA in porcine thyroid: comparison with KIO3 and nDNA

Astaxanthin from shrimp by-products ameliorates nephropathy in diabetic rats

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin